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Hypoxia/reperfusion i jury is a major clinical problem. One of its hallmarks is an increased cytosolic Ca” content and an increased generation 
of reactive oxygen species in the cytosol and in mitochondria. In the present study of an in vitro model of hypoxialreperfusion i jury, mitochondria 
are exposed to Ca*’ in combination with extra- and intramit~hond~ally acting prooxidants. In this model mit~hond~a are damaged in a 
Ca2”-dependent manner. The extent and the site(s) of damage depend on both the kind of respiratory substrate and prooxidant used. The major 
damage occurs specifically at site I of the respiratory chain, and is due to hydrolysis of oxidized pyridine nucleotides and Ca” release followed 
by Ca*’ re-uptake (Ca’+ ‘cycling’). Cyclosporine A completely protects against his damage. The protection is due to inhibition of pyridine nucleotide 
hydrolysis, an obligatory step in the sequence of events that links prooxidants to Cal’ release from intact mitochondria. 
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1. INTRODUCTION 
A major problem in organ infarct or transplantation 
is h~oxi~reperfusion injury (HRI), where an initial, 
rather innoxious deprivation of oxygen and energy is 
followed upon re-oxygenation by major damage. A 
hallmark of HRI is an increased cytosolic Ca2’ content 
caused by hypoxia, followed by an increased generation 
of reactive oxygen species in the cytosol and in mito- 
chondria subsequent to re-oxygenation [1,2]. These or- 
ganelies have a pivotal role in HRI: on the one hand, 
they are a safety device against a toxic increase of the 
cytosolic Ca2’ concentration, because they can take up 
and transiently store large amounts of Ca” with impu- 
nity; on the other hand, an ongoing release of Ca’+, 
which can be induced by prooxidants, followed by Ca2* 
re-uptake (Ca” ’ cycling’) damages mitochondria and 
can lead to cell death [3-51. 
mitochondria are damaged in a Ca”-dependent man- 
ner, and that the extent and site(s) of damage depend 
on both the kind of respiratory substrate and of proox- 
idants used; (ii) the major damage is due to hydrolysis 
of oxidized pyridine nucleotides followed by Ca2’ cy- 
cling; (iii) this damage is effectively prevented by a ther- 
apeutically relevant concentration of cyclosporine A 
(CSA). 
2. MATERIALS AND METHODS 
2.1. Materials 
CSA was a gift of Sandoz Pharma Preclinical Research, Basel, 
Switzerland. It was stored in solid form at -20°C and dissolved in 
ethanol immediately prior to use. All other chemicals were purchased 
from standard suppliers, and were of the highest purity commercially 
available. 
2.2. Isolation of mitochondria 
In the present in vitro study we investigated the re- 
sponse of mitochondria to conditions that prevail in 
HRI, i.e. relatively high Ca2’ concentrations in combi- 
nation with extra- and intra~t~hondriaily acting 
prooxidants. We found that under these conditions (i) 
The isolation of rat liver mitochondria was performed by differen- 
tial centrifugation. Briefly, livers were homogenized in ice-cold buffer 
(210 mM mannitol, 70 mM sucrose, and 5 mM 4-(2-hydroxyethyl)-l- 
pi~r~n~ulphonic acid containing 1 mM of the chelator, ethylenedi- 
~inetetraacetic acid. The mitochond~al pellet obtained after the 
high-speed centrifugation was washed once in the same buffer without 
the chelator. The protein content was determined by the Biuret 
method with BSA as standard. 
*Corresponding author. Fax: (41) (1) 261 5677. 
**Permanent address: Institute of Theoretical and Experimental Bio- 
physics, Russian Academy of Sciences, ~shch~o 142292, Russian 
Federation. 
2.3. Labelling of mitochondrial pyridine nucleotides in vivo 
Overnight-fasted rats were injected intravenously with [carboxyf- 
Y@cotinic acid (12.5 &i, 0.223 pmol) [q in phosphate-buffered 
saline. After 3 h, the animals were killed, and liver mitochondria were 
isolated. 
Abbreviations: CSA, cyclosporine A; EGTA, ethylene glycol his@ 
aminoethyl ether)-N,N,N’,W-tetraacetic acid; CCCP, carbonyl cya- 
nide m-chlorophenylhydrane; HRI, hypoxialreperfusion injury; 
RCI, respiratory control index; tbh, r-butylhydroperoxide; XO/HX/ 
Fe, xanthine oxidas~h~xanthin~iron ions. 
2.4. Standard incubation procedure 
Mitochondria were incubated at 25°C with continuous tirring, and 
in the case of nicotinamide release measurements with oxygenation, 
in 100 mM KCI, 100 mM sucrose, 5 mM Tris, pH 7.4, ~ntaining 1 
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mM KH~~~wjth 5 mM ~-hydroxybutyrate or 5 mM succinate as 
respiratory substrates. 
A Mt EGTA 
i 1 
2.5. ~itacha~ria~ res~~Tatian 
This was measured with a Clark-type electrode. Mit~hond~a were 
incubated according to the standard procedure with a protein content 
of 1.5 mgfml. The respiratory control index (RCI) was calculated as 
the ratio of the rate of oxygen consumption during (state 3) and after 
(state 4) ADP-stimulated respiration [7]. The statistical analysis was 
done by a Student’s r-test. 
2.6. Pyridfne nueleotide hydrolysti 
Mitochondrial pyridine nuleotides were labelled in vivo (see above), 
mit~hond~a were isotated, and incubated at 1 mg of proteimml 
according to the standard procedure, Nicotin~ide release was ana- 
tyzed by Millipore filtration as described [6]. 
3. RESULTS 
Fig. 1 reports mit~hondrial oxygen consumption 
supported by the site I respiratory substrate /?-hy- 
droxybutyrate. Mitochondria in the presence of EGTA 
are tightly coupled (Fig. lA, trace a). Exposure of these 
mitochondria to the prooxidant ~-butylhydroperoxide 
(tbh) (Fig. lA, trace b), which is metabolized intramito- 
chondrially 183, or to Ca2” (Fig. lA, trace c) leaves their 
degree of coupling and maximal respiration essentially 
unaffected. In contrast, tbh and Ca2’ together uncouple 
mitochondria and decrease their maximal respiration 
(Fig. lA, trace d). CSA prevents the mitochondrial dete- 
rioration induced by the combined presence of tbh and 
Ca2” (Fig. lA, trace e). Similar results are obtained 
when tbh is replaced by the extramitochondrial genera- 
tor of oxygen radicals and hydrogen peroxide, xanthine 
oxidaseihypoxanthineliron ions (XO/HX/Fe) (Fig. 1 B), 
except that the damage observed under these conditions 
is more pronounced. Fig. 2 compiles the respiratory 




With respiration supported by the site II substrate, 
succinate, mitochondria had a respiratory control index 
(RCI) of 3.5. tbh and Ca2+ alone or in combination 
neither affected the degree of coupling nor the maximal 
respiration (results not shown). 
Prooxidant-induced Ca” release from mitochondria, 
followed by Ca2+ cycling, causes selective damage of site 
I of the respiratory chain (Fig. 3). Thus, when tbh is 
Fig. 1. Mit~hond~al respiration supported by 5 mM B-hydroxybu- 
tyrate in the presence of prooxidants. Mitochondria (Mt) were incu- 
bated according to the standard procedure. Respiration was measured 
with a Clark-type electrode (see section 2). EGTA (5 mM), ADP (150 
PM), and the uncoupler CCCP were added as indicated by the arrows 
and triangles. (A) tbh as prooxidant; trace a, control; trace b, as trace 
a + tbh; trace c, as trace a + Ca*’ (20 mnollmg of protein); trace d, 
as trace a + tbh and Ca” ; trace e, as trace d + CSA. (B) XO/HX./Fe 
as prooxidant; trace a, XO/HX/Fe; trace b, as trace a + Ca*+ (20 
nmoU mg of protein); trace c, as trace b + CSA. XO/HX/Fe, 0.02 U 
xanthine oxidaselml, 15 FM hypoxanthine, 15 pM Fe,SO,; tbh, 30 
PM; CCCP, 0.5 pM; CSA, 1 .uM; EGTA, 5 mM. 
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Fig. 2. Respiration rate and respiratory control index. Mitochondrial respiration supported by 5 mM ,&hydroxybutyrate in the presence of the 
prooxidants, tbh or XO/HX/Fe, was measured as in Fig. 1. Respiratory control indices were calculated as described in section 2. Data are expressed 
as mean + S.E.M. (n = 4-6); *P < 0.05; **P < 0.01; ***P < 0.005. V,, respiration rate in state 3; V,, respiration rate in state 4, V,,, respiration 
rate in the presence of uncoupler; RCI, respiratory control index. 
added to Ca*‘-loaded mitochondria, /%hydroxybu- 
tyrate-supported respiration initially increases, then de- 
creases and becomes unresponsive to the uncoupler; 
however, these mitochondria remain fully responsive to 
succinate (Fig. 3, trace a). CSA (Fig. 3, trace b) or 
EGTA (Fig. 3, trace c) protect mitochondria from the 
prooxidant + Ca2”-induced, site I-specific damage. The 
same results were obtained with XO/HX/Fe instead of 
tbh (not shown). 
In Ca2”-loaded mitochondria respiring on @-hy- 
droxybutyrate, extensive hydrolysis of pyridine nucleo- 
tides occurs, as judged from nicotinamide release (Fig. 
4A, traces a-c). Even without added prooxidant hydrol- 
ysis takes place (Fig. 4A, trace a) because in &hy- 
droxybutyrate-energized mitochondria Ca*’ uptake 
causes extensive pyridine nucleotide oxidation (result 
not shown), a prerequisit for their hydrolysis. Hydroly- 
sis is stimulated by prooxidants, either generated ex- 
tramitochondrially (Fig. 4A, trace b), or being metabol- 
ized intramitochondrially (Fig. 4A, trace c). CSA com- 
pletely prevents pyridine nucleotide hydrolysis induced 
by either prooxidant (Fig. 4A, traces d and e). No hy- 
drolysis takes place in Ca*+-depleted mitochondria ex- 
posed to the prooxidants (Fig. 4A, traces f and g). With 
succinate as the respiratory substrate (Fig. 4B) pyridine 
nucleotide hydrolysis is very limited despite the joint 
presence of prooxidant and Ca”, because succinate 




To mimick in an in vitro model the conditions pre- 
vailing upon reperfusion after hypoxia, in the present 
study isolated rat liver mitochond~a were energized and 
exposed to Ca’+ and prooxidants which act intra- or 
extramitochondrially. Several conclusions can be drawn 
from the results obtained. (i) When mitochondria con- 
tain oxidized pyridine nucleotides and Ca” they experi- 
ence specific damage at site I of the respiratory chain. 
(ii) Not simply the exposure to prooxidants and Ca”’ is 
deleterious to mitochondria, but the prooxidant-in- 
duced stimulation of the Ca2+ release pathway, which 
requires pyridine nucleotide hydrolysis, followed by 
Ca” cycling. This is evident from the transient increase 
in ~-hydroxybutyrate-supported respiration due to in- 
creased Ca*’ cycling followed by inhibition of respira- 
tion, and from the protection by CSA and EGTA, com- 
pounds which prevent pyridine nucleotide hydrolysis 
and/or Ca2+ cycling, respectively. (iii) CSA, at a thera- 
peutically relevant concentration [9], completely pro- 
tects mitochondria in this in vitro model of HRI. 
CSA protects mitochondria by inhibiting the hydrol- 
ysis of oxidized pyridine nucleotides, an obligatory step 
in the sequence of events leading to Ca2* release and 
subsequent Ca2+ cycling [4], whereas succinate protects 
by keeping mitochondrial pyridine nucleotides largely 
reduced. Some of the radioactivity lost from mitochon- 
dria may also be attributed to intact pyridine nucleo- 
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tides since, in the presence of CSA or EGTA, the inner 
mitochondrial membrane may become non-specifically 
permeable [10,17]. The production by succinate is due 
to reversed electron flow, as will be described in detail 
elsewhere. Pyridine nucleotide hydrolysis is also the 
cause of the site I-specific inhibition of respiration in the 
presence of prooxidants and Ca2’, as is evident from 
protection by CSA or succinate. 
Our findings confirm and extend previous reports. 
Thus, CSA prevents prooxidant-indu~d Ca*’ release 
from isolated heart [IO], liver [11,12], and kidney [13] 
mitochondria. The drug also protects hepatocytes 
against prooxidant-induced mitochondrial Ca*’ cycling 
and cell killing 1141. Specific loss of site I activity of 
kidney mitochondria exposed to the oxygen radical gen- 
erator XOIHX/Fe and Ca*’ has been reported [lS], but 
the underlying mechanism was not elucidated. It has 
also been shown that CSA restores ATP synthesis and 
coupling in mitochondria not before but after reperfu- 
sion of previously hypoxic rat liver [16]. It therefore 
appears that CSA, in addition to its immunosuppressive 
properties, is useful to mitigate HRI-related organelle, 
cell, and organ damage caused by prooxidant-induced 
mitochondrial Ca*’ cycling. 
Fig. 3. r-Butylhydroperoxide-induced uncoupling and inhibition of 
mitochondrial respiration. Mitochondria were incubated according to 
the standard procedure in the presence of 5 mM /Lhydroxybutyrate. 
Respiration was measured with a Clark-type electrode (see section 2). 
Ca*’ (20 nmoilmg of protein), tbh, the uncoupler CCCP, and succinate 
were added as indicated by the arrows and triangles. Trace a, control; 
trace b, as trace a + CSA, trace c, as trace a + EGTA. Succ, 5 mM; 
tbh, 30 PM; CCCP, 0.5 FM; CSA, I PM; EGTA, 5 mM. 
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Fig. 4. Hydrolysis of mitochondrial pyridine nucleotides. Mitochon- 
dria labelled at the nicotinamide moiety were incubated (time 0 min) 
according to the standard procedure After 30 s they were exposed to 
20 nmol of Ca’+/mg of protein (lanes a-e), and 2 min later the proox- 
idant was added as indicated below. Pyridine nucleotide hydrolysis 
was analyzed by determination of nicotinamide release with Millipore 
filtration. (A) 5 mM #%hydroxybutyrate s respiratory substrate; trace 
a, Ca*’ (20 nmollmg of protein); trace b, as trace a + XO/HX/Fe; trace 
c, as trace a plus tbh; trace d, as trace b + CSA; trace e, as trace 
c+CSA; traces f and g, mitochondria were depleted of Ca*+ with 5 mM 
EGTA prior to addition p-hydroxybutyrate and at time 2 min 15 set 
exposed to XO/HX/Fe (trace f) or tbh (trace g). (B) 5 mM succinate 
as respiratory substrate; trace a, Ca” (20 nmol/mg of protein); trace 
b, as trace a + XO/HX/Fe; trace c, as trace a + tbh. XO/HX/Fe, 0.02 
U xanthine oxidase/ml, 15 PM hypoxanthine, 15 pM Fe,SO,; tbh, 30 
PM; CSA, I pM; EGTA, 5 mM. 
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